Professor Godfrey is an immunologist with a long standing history as a pioneer in the study of a specialised type of white blood cell, known as NKT cells. NKT cells are activated in response to lipid-based molecules that are thought to alert the immune system, via NKT cell activation, to the presence of infectious agents or other abnormalities. A better understanding of how NKT cells function will provide new approaches to battling a broad range of diseases where these cells are implicated, incl ....Professor Godfrey is an immunologist with a long standing history as a pioneer in the study of a specialised type of white blood cell, known as NKT cells. NKT cells are activated in response to lipid-based molecules that are thought to alert the immune system, via NKT cell activation, to the presence of infectious agents or other abnormalities. A better understanding of how NKT cells function will provide new approaches to battling a broad range of diseases where these cells are implicated, including cancer, autoimmunity, allergy and infection.Read moreRead less
This application will increase the impact of cancer immunotherapy on disease prevention and treatment, by developing new targets and novel combination immunotherapies. Outcomes will include an improved understanding of the immune reaction with cancer and more effective strategies to prevent cancer spread and safely target and eradicate a larger proportion of established and advanced malignant disease.
Using Big Data To Improve Medication Use And Safety
Funder
National Health and Medical Research Council
Funding Amount
$851,980.00
Summary
More than 1 in 3 Australians report having 3 or more chronic conditions and the majority of older people now take 5 or more medicines. The safety of medicines on their own, and in combination is therefore an issue of significant importance to Australia. This research will develop and assess data methods to monitor the safety of medicines after they are released on the market and then provide and assess interventions for GPs to support improvements in medicine use.
Understanding the immune response is proving extremely complex and promising results for disease treatments from animal models are often difficult to translate to new clinical therapies. My research is unearthing weaknesses in our current knowledge of the immune system and seeking to replace them with a foundation that can exploit new developments in computer modelling and systems biology. In this way I aim to rationally manipulate the immune response.
Understanding Immune Regulation During Parasitic Diseases.
Funder
National Health and Medical Research Council
Funding Amount
$631,010.00
Summary
Chronic infectious diseases such as HIV/AIDS, tuberculosis, malaria and leishmaniasis are responsible for significant morbidity and mortality. They are all characterised by severe immune dysfunction. We will study a parasitic infection to identify important immune cell populations and molecules that promote chronic infectious disease. This knowledge will enable the development of better treatments and vaccines for range of infectious diseases that affect people in many parts of the world.
Defining The Requirements For Effective Immune Responses
Funder
National Health and Medical Research Council
Funding Amount
$714,745.00
Summary
The immune system rapidly responds to infectious pathogens to eradicate such microbes and limit the damage they can inflict upon the host. Individuals with primary immunodeficiencies have defects in the development and/or function of the cells of their immune system and are more susceptible to infectious diseases. This study will investigate such individuals to identify functions for specific genes and immune cells in order to understand the requirements for generating effective immune responses ....The immune system rapidly responds to infectious pathogens to eradicate such microbes and limit the damage they can inflict upon the host. Individuals with primary immunodeficiencies have defects in the development and/or function of the cells of their immune system and are more susceptible to infectious diseases. This study will investigate such individuals to identify functions for specific genes and immune cells in order to understand the requirements for generating effective immune responses.Read moreRead less
The development of protective immunity is essential to fight infection. This depends on a small number of master regulatory transcription factors that drive the differentiation of precursor cells into mature immune cells such as NK, T and dendritic cells. This proposal will provide a fundamental advance in our understanding of immune cells and impact strategies aimed at the prevention and treatment of pathogen infections.
Delineating Immune Circuits For Innate And Adaptive Immune Protection
Funder
National Health and Medical Research Council
Funding Amount
$876,005.00
Summary
The immune system provides the essential frame-work to protect us against infection, disease and to heal tissues after trauma. This is achieved by a complex but elegant network of different types of white blood cells. Understanding the molecular wiring of these cells will provides fundamental insights to how the body fights pathogen infections and cancer and lays the foundation to therapeutic approaches to vaccination and disease treatments.
Towards HIV And Hepatitis C Elimination: Real-world Trials And Innovations In Disease Surveillance
Funder
National Health and Medical Research Council
Funding Amount
$640,210.00
Summary
Over the next five years I will undertake a program of research centred on developing and implementing strategies to help eliminate hepatitis C and HIV as major public health problems. In particular, I will use innovative monitoring systems and field trials to explore ways to diagnose and treat HIV and hepatitis C in vulnerable populations in a more timely way and study the influence this has on reducing the onward transmission of these infections to others.
Evaluations For Efficient And Effective Public Health Responses To HIV Epidemics
Funder
National Health and Medical Research Council
Funding Amount
$699,190.00
Summary
I will lead studies on evaluating population impact and calculating cost-effectiveness of public health prevention programs for HIV/AIDS epidemics in Asia and Eastern Europe. Return on Investment analyses will inform Ministries of Finance about overall budget allocations. Effectiveness and efficiency evaluations and determining optimal allocations of funding mixes will directly inform Ministries of Health in planning program implementation in 15-20 countries in the region.